International Cannabis Weekly: 239
UK MEDICAL CANNABIS TRIALS ARE SET TO START IMMINENTLY
Large–scale trials of medical cannabis in the UK will begin ‘as soon as possible’, the Department of Health and Social Care has said. The government’s National Institute for Health Research is to oversee the studies – which will look at the effects of the substance on epilepsy sufferers.
The NHS currently only prescribes cannabis-based medicines as a last resort and says ‘very few people in England are likely to get a prescription’ for it. But some people with epilepsy, multiple sclerosis, or undergoing chemotherapy say the drug can help relieve pain and nausea and should be more easily available in a medical setting.
MILAN CITY COUNCIL VOTES IN FAVOUR OF CANNABIS LEGALISATION
MEDICAL CANNABIS PRESCRIPTIONS DOUBLE IN THE LAST YEAR IN AUSTRALIA
- It’s five years since German medical cannabis legalisation, but experts are frustrated with lack of progress.
- Europe establishes a new maximum level of THC content allowed in hemp food products.
- Data released from the UK FSA confirms that 89 more Novel Foods applications have been validated for the UK public list.
- Akanda Corp is the latest British cannabis company to go public after it launched on the NASDAQ stock exchange.
- A significant Love Hemp investor is demanding that the company’s chairman is removed.
- One year on from the first LSE cannabis stock listing, a number of companies look to list in 2022.
- Italian firm Bio Hemp Farming has created a processing centre to turn out biomass for medical-grade CBD.
- This month Xebra will harvest medical cannabis as part of a pilot project run by the Dutch government.
- State treasurers from across the US discuss cannabis banking challenges as part of a three-day conference.
- Members of Congress have called for the US FDA to establish a regulatory framework for CBD.
- A Rhode Island Senate committee discusses a bill to legalise cannabis in the state.
- The Oregon legislature passes a bill that prohibits the issuance of cannabis licences until 2024.
- Schwazze signs a definitive document to acquire all the assets of Urban Health and Wellness.
- The last of three scheduled hearings has been held on cannabis legalisation in Pennsylvania.
- Clever Leaves announced that it has appointed William Muecke to its board of directors.
- Agrify Corporation announces that it has entered into a financing agreement for US$135 million in a secured note facility.
- Praetorian Global announces the acquisition of cannabis firm Oni Seed, along with all of its assets.
- Glass House Brands announces that it has secured a California state county cultivation licence.
- Quebec’s ban on cannabis home cultivation is set to be reviewed by the Supreme Court.
- Pineapple Express, a subsidiary of Fire and Flower, has launched a next-day cannabis delivery service.
- The federal government in Ottawa has proposed new regulations that would relax restrictions on cannabis drinks.
- The Canada Cannabis Spot Index has increased by 1% from last week, climbing to C$5.13 per gram.
- Cannabis grower CannTrust has secured investment from a Dutch private equity firm.
- Cannabis company Adastra Holdings has sealed a private manufacturing agreement with Zyre Brands.
SPONSORSHIP APPLICATION FOR THE EUROPEAN CANNABIS REPORT 7TH EDITION CLOSE ON MONDAY
Sponsorship applications for The European Cannabis Report: 7th Edition close on Monday 21 March at 12pm BST. Apply today to learn more about the range of sponsorship opportunities available.
Position your brand at the forefront of the global cannabis industry and speak directly to our audience of investors, operators and regulators. Be part of the cannabis conversation and drive real change in the European cannabis industry.
LATAM & The Caribbean
- Mexico needs federal government support to make cannabis a global opportunity and boost the economy.
- CENPAT informs the residents of Chubut that it is not authorised to deliver or sell cannabis oil.
- On 2 April in Merlo, ‘Sierra Cultiva’ will be held, a day dedicated to learning more about cannabis.
- Guyana looks to hemp cultivation as a way of combating a struggling agricultural sector.
- AYA Natural and Medical Products begins producing cannabis on an industrial scale in Ecuador.
- Anvisa has set up a webinar to discuss the import and export of controlled substances.
- Cannatrek has now started the construction of its medical cannabis facility in Victoria.
- Despite heavy regulations in New Zealand, the cannabis industry is delivering for patients and the economy.
- Australian firm Emyria focuses on CBD trials as it looks to the low-dose prescription-free cannabidiol market.
- The INCB is surveying civil society groups about their position on cannabis scheduling.
- The ODC has granted Cann Group a permit to allow commercial cultivation of medical cannabis in Mildura.
Africa & The Middle East
- The Israeli Ministry of Health reveals that the number of medical cannabis patients is increasing every month.
- Israel starts work on decriminalising CBD, despite a thriving medical cannabis industry.
- IM Cannabis Corp. completes three acquisitions, including Vironna, one of the largest pharmacies in Israel.
- The KwaZulu government will set up a cannabis council to oversee the development of the industry.
- A new ‘commercial use’ clause added to the South African cannabis bill causes legal confusion.
On the global cannabis industry
International Cannabis Weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry. Join our community of 70,000+ subscribers.